Use of the GeneReader NGS System in a clinical pathology laboratory: a comparative study

Despite its successful use in academic research, next-generation sequencing (NGS) still represents many challenges for routine clinical adoption due to its inherent complexity and specialised expertise typically required to set-up, test and operate a complete workflow.This study aims to evaluate QIAGEN's newly launched GeneReader NGS System solution in a pathology laboratory setting by assessing the system's ease of use, sequencing accuracy and data reproducibility. Our laboratory was able to implement the system and validate its performance using clinical samples in direct comparison to an approved Sanger sequencing platform and to an alternative in-house NGS technology. The QIAGEN workflow focuses on clinically actionable hotspots maximising testing efficiency. Combined with automated upstream sample processing and integrated downstream bioinformatics, it offers a realistic solution for pathology laboratories with limited prior experience in NGS technology.

• Publication year

  2017

• Venue

  Journal of Clinical Pathology

• Publication date

  2017-04-11

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1136/jclinpath-2017-204342PMID 28400467PMCID 5537555
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [The new challenge in oncology: Next-generation sequencing and its application in precision medicine].

  2016cited by this paper
• HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers

  2016cited by this paper
• LYMPHOID NEOPLASIA B-cell – speci fi c conditional expression of Myd88 p.L252P leads to the development of diffuse large B-cell lymphoma in mice by Sequencing Project

  2016cited by this paper
• Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

  2016cited by this paper
• B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice.

  2016cited by this paper
• Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls

  2016cited by this paper
• Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity

  2015cited by this paper
• Analysis of Pre-Analytic Factors Affecting the Success of Clinical Next-Generation Sequencing of Solid Organ Malignancies

  2015cited by this paper
• Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing

  2015cited by this paper
• HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinib.

  2015cited by this paper
• Comparison of Pre-Analytical FFPE Sample Preparation Methods and Their Impact on Massively Parallel Sequencing in Routine Diagnostics

  2014cited by this paper
• Activating Mutations in ERBB2 and Their Impact on Diagnostics and Treatment

  2013cited by this paper

• An Overview of Advances in Rare Cancer Diagnosis and Treatment

  2024cites this paper
• Exploring a novel model for newborn genetic screening in Ningxia, northern China: A retrospective observational study

  2024cites this paper
• A Comprehensive Review of Performance of Next-Generation Sequencing Platforms

  2022cites this paper
• FFPE-Based NGS Approaches into Clinical Practice: The Limits of Glory from a Pathologist Viewpoint

  2022cites this paper
• The prevalence of tumour markers in malignant pleural effusions associated with primary pulmonary adenocarcinoma: a retrospective study

  2021cites this paper
• Third generation sequencing and the evolution of NGS

  2021cites this paper
• Circulating exosomal miR-125a-5p as a novel biomarker for cervical cancer

  2020cites this paper
• Pathogenicity and Virulence Factors of Fusarium graminearum Including Factors Discovered Using Next Generation Sequencing Technologies and Proteomics

  2020cites this paper
• Comparison of four high throughput sequencing platforms in a medical laboratory for gut microbiome research

  2020cites this paper
• NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program

  2020cites this paper
• NEXT-GENERATION SEQUENCING (NGS): OUR RESULTS OF MOLECULAR PATHOLOGY MALIGNANT SOLID TUMOR PANEL.

  2019cites this paper
• Genomic Applications in Pathology

  2019cites this paper
• Next-Generation Sequencing in Clinical Practice

  2019cites this paper
• Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients

  2018cites this paper
• All‐in‐one: The dream and reality of molecular cytopathology testing on routine lung cancer smears

  2018cites this paper
• DNA-Based Sequencing Assays

  2018cites this paper
• Genomic Applications in Pulmonary Malignancies

  2018cites this paper
• Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples

  2018cites this paper
• Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer

  2018cites this paper
• Use of the Ion AmpliSeq Cancer Hotspot Panel in clinical molecular pathology laboratories for analysis of solid tumours: With emphasis on validation with relevant single molecular pathology tests and the Oncomine Focus Assay.

  2018cites this paper
• Pre-clinical validation of a next generation sequencing testing panel.

  2018cites this paper
• Transformation of animal genomics by next-generation sequencing technologies: a decade of challenges and their impact on genetic architecture

  2018cites this paper
• Liquid Biopsy and Therapeutic Targets: Present and Future Issues in Thoracic Oncology

  2017cites this paper
• ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice

  2017cites this paper